![Jeannette Joughin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: - $ in data 31/05/2026
Jeannette Joughin is currently an Independent Non-Executive Director at Vitrafy Life Sciences Ltd. since 2026.
Other current roles include Non-Executive Director at Bivacor Pty Ltd., ImmVirX Pty Ltd., BiVACOR, Inc., and the Australian Institute of Co. Directors as a Member.
Since 2024, Non-Executive Director at Immuron Ltd. and Argenica Therapeutics Ltd. Since 2021, Venture Partner at OneVentures Management Pty Ltd. Former roles include Non-Executive Director at Glutagen Sales Pty Ltd. from 2019 to 2020, Director-Pharmaceuticals Marketing at Seqirus GmbH, Non-Executive Director at Paranta Biosciences Ltd. from 2019 to 2022, Vice President at CSL Behring LLC from 2010 to 2015, Marketing Manager at Mayne Pharma Ltd. from 2000 to 2004, Clinical Research at Bristol Myers Squibb Co. from 1992 to 1999, Chief Commercial Officer & Executive VP at Enable Injections, Inc. from 2015 to 2019, and Chief Operating Officer at Paradigm Biopharmaceuticals Ltd. from 2020 to 2021.
Education includes undergraduate and doctorate degrees from Monash University, conferred in 1985 and 1988 respectively.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
IMMURON LIMITED -.--% | 18/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| IMMURON LIMITED | Direttore/Membro del Consiglio | 01/06/2024 |
| ARGENICA THERAPEUTICS LIMITED | Direttore/Membro del Consiglio | 02/12/2024 |
ImmVirX Pty Ltd.
 ImmVirX Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Develops oncotic viral immunotherapy | Direttore/Membro del Consiglio | - |
Australian Institute of Co. Directors
 Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Corporate Officer/Principal | - |
BiVACOR, Inc.
 BiVACOR, Inc. Medical SpecialtiesHealth Technology Develops and manufactures medical devices | Direttore/Membro del Consiglio | - |
OneVentures Management Pty Ltd.
 OneVentures Management Pty Ltd. Investment ManagersFinance OneVentures invests in companies located in Australia. The firm targets on companies operating in the fields of healthcare and technology sectors. It provides financing for early and growth stage capital requirements. | Investitore di Private Equity | 01/08/2021 |
Bivacor Pty Ltd. | Direttore/Membro del Consiglio | - |
| Società | Posizione | Fine |
|---|---|---|
Paranta Biosciences Ltd.
 Paranta Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Develops PB01 (recombinant human follistatin-288) for the treatment of fibrotic and inflammatory diseases | Direttore/Membro del Consiglio | 01/06/2022 |
| PARADIGM BIOPHARMACEUTICALS LIMITED | Direttore operativo | 30/06/2021 |
| ░░░░░░░░ ░░░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 16 |
|---|---|
Monash University
 Monash University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immuron Ltd.
 Immuron Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
CSL Behring LLC
 CSL Behring LLC BiotechnologyHealth Technology Manufactures and markets plasma protein products | Health Technology |
Mayne Pharma Ltd.
 Mayne Pharma Ltd. Pharmaceuticals: OtherHealth Technology Manufactures pharmaceutical products | Health Technology |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Commercial Services |
Bristol Myers Squibb Co. /Australian Pharmaceutical Mfg Ops/
 Bristol Myers Squibb Co. /Australian Pharmaceutical Mfg Ops/ Pharmaceuticals: MajorHealth Technology Manufactures drugs and pharmaceutical products | Health Technology |
Seqirus GmbH
 Seqirus GmbH BiotechnologyHealth Technology Develops and produces flu vaccines | Health Technology |
Glutagen Sales Pty Ltd.
 Glutagen Sales Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Develops enzyme therapies for the treatment of gluten intolerance and coeliac disease | Commercial Services |
OneVentures Management Pty Ltd.
OneVentures Management Pty Ltd. Investment ManagersFinance OneVentures invests in companies located in Australia. The firm targets on companies operating in the fields of healthcare and technology sectors. It provides financing for early and growth stage capital requirements. | Finance |
BiVACOR, Inc.
BiVACOR, Inc. Medical SpecialtiesHealth Technology Develops and manufactures medical devices | Health Technology |
Enable Injections, Inc.
 Enable Injections, Inc. Medical SpecialtiesHealth Technology Develops wearable drug delivery technology for investigational use in the pharmaceutical and biotechnology industries | Health Technology |
Paranta Biosciences Ltd.
Paranta Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Develops PB01 (recombinant human follistatin-288) for the treatment of fibrotic and inflammatory diseases | Health Technology |
Paradigm Biopharmaceuticals Ltd.
 Paradigm Biopharmaceuticals Ltd. Pharmaceuticals: GenericHealth Technology Engages in repurposing the drug, pentosan polysulphate sodium for the treatment of bone marrow edema | Health Technology |
Bivacor Pty Ltd. | |
ImmVirX Pty Ltd.
ImmVirX Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Develops oncotic viral immunotherapy | Commercial Services |
Argenica Therapeutics Ltd.
 Argenica Therapeutics Ltd. BiotechnologyHealth Technology Develops novel neuro protective therapeutics to reduce brain damage | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
